Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Well conducted study, Guideline study, GLP, carried out by Nihon Bioresearch Inc. Hashima Laboratory.
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1998
Reference Type:
review article or handbook
Title:
Unnamed
Year:
1998

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: OECD TG 422
Principles of method if other than guideline:
OECD Combined Repeated Dose and Reproductive/Developmental Toxicity Screening Test
GLP compliance:
yes

Test material

Constituent 1
Reference substance name:
2-ethylhexyl methacrylate
EC Number:
211-708-6
EC Name:
2-ethylhexyl methacrylate
Cas Number:
688-84-6
IUPAC Name:
2-ethylhexyl methacrylate
Details on test material:
2-ethylhexyl methacrylate
Purity: 99.4 %

Test animals

Species:
rat
Strain:
Crj: CD(SD)

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Duration of treatment / exposure:
Males, 49 days                      
Female, from 14 days before mating to  day 3 of lactation
Frequency of treatment:
daily
Doses / concentrations
Remarks:
Doses / Concentrations:
0 (vehicle), 30, 100, 300, 1000 mg/kg/day
Basis:

No. of animals per sex per dose:
12 (males) and 12 (females)/group
Control animals:
yes
Details on study design:
Terminal sacrifice: Males: 50 days; Females, day 4 of lactation

Results and discussion

Results: maternal animals

Effect levels (maternal animals)

open allclose all
Dose descriptor:
NOAEL
Effect level:
300 mg/kg bw/day
Basis for effect level:
other: developmental toxicity
Dose descriptor:
LOAEL
Effect level:
1 000 mg/kg bw/day (nominal)
Basis for effect level:
other: developmental toxicity
Dose descriptor:
NOAEL
Effect level:
100 mg/kg bw/day
Basis for effect level:
other: maternal toxicity
Dose descriptor:
LOAEL
Effect level:
300 mg/kg bw/day (nominal)
Basis for effect level:
other: maternal toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:yes

Details on embryotoxic / teratogenic effects:
Decreased birth, live birth and viability indices, and decreased body weights of both sexes on day 0 and day 4 after birth were seen in the 1000 mg/kg group.

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
In a valid guideline study, decreased birth, live birth and viability indices, and decreased body weights of both sexes on day 0 and day 4 after birth were seen in the 1000 mg/kg group.
Executive summary:

In a valid guideline study, decreased birth, live birth and viability indices, and decreased body weights of both sexes on day 0 and day 4 after birth were seen in the 1000 mg/kg group.